HEPATO CELLULAR CARCINOMA (HCC)
Clinical trials for HEPATO CELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new HEPATO CELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for HEPATO CELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for liver cancer: smart trial aims to match patients with best Second-Line therapy
Disease control Recruiting nowThis study tests several new drug combinations in 350 adults with advanced liver cancer whose first treatment stopped working. The goal is to quickly find which therapy works best and to use tumor and blood tests to personalize treatment. Participants will receive one of the inve…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
Poop pills could rescue liver cancer patients when drugs fail
Disease control Recruiting nowThis study tests whether a fecal microbiota transplant (FMT) can help people with advanced liver cancer whose disease worsened on standard immunotherapy. About 15 participants will receive FMT along with resuming their original drugs. The goal is to see if this combination can co…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
New drug cocktail shows promise in slowing advanced liver cancer
Disease control Recruiting nowThis study tests whether adding chemotherapy to a combination of two drugs (camrelizumab and apatinib) helps people with advanced liver cancer live longer without their disease getting worse. About 326 adults with liver cancer that cannot be removed by surgery will be randomly as…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE3 • Sponsor: Linhui Peng • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
Liver cancer trial aims to boost chemo effectiveness with blood pressure drug
Disease control Recruiting nowThis study tests whether adding a blood pressure drug (nicardipine) to standard chemo delivered directly to the liver (TACE) can improve outcomes for people with liver cancer. About 152 adults with a single untreated tumor will be randomly assigned to receive either TACE plus nic…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2, PHASE3 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New blood test could detect liver cancer before It's too late
Diagnosis Recruiting nowThis study is testing a new blood test called Delta-HLD to see if it can accurately detect liver cancer (hepatocellular carcinoma). Researchers will compare blood and tissue samples from 100 people with liver cancer and 100 people with liver cirrhosis (but no cancer). If successf…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Sponsor: Epiliquid Holding, Inc • Aim: Diagnosis
Last updated May 26, 2026 10:27 UTC
-
Liver cancer patients may skip hospital stay in new study
Symptom relief Recruiting nowThis study tests whether people with liver cancer can receive a treatment that goes into the liver's blood vessels (called TACE or TARE) as an outpatient instead of staying overnight in the hospital. About 206 adults with primary liver cancer will be randomly assigned to either o…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: NA • Sponsor: University Hospital, Angers • Aim: Symptom relief
Last updated May 20, 2026 11:56 UTC